Benefits of endoscopic gallbladder stenting following percutaneous transhepatic gallbladder drainage  

作　　者：Fumitaka Niiya Naoki Tamai Masataka Yamawaki Jun Noda Tetsushi Azami Yuichi Takano Fumiya Nishimoto Masatsugu Nagahama 

机构地区：[1]Division of Gastroenterology,Department of Internal Medicine,Showa University Fujigaoka Hospital,Yokohama 227-8501,Kanagawa,Japan

出　　处：《World Journal of Gastrointestinal Surgery》2024年第9期2902-2909,共8页世界胃肠外科杂志（英文版）（电子版）

摘　　要：BACKGROUND Endoscopic transpapillary gallbladder drainage is challenging because of the complexity of the procedure and high incidence of adverse events(AEs).To overcome these problems,endoscopic gallbladder stenting(EGBS)after percutaneous transhepatic gallbladder drainage(PTGBD)can be effective,as it mitigates inflammation and adhesion.AIM To examine the benefits of EGBS after PTGBD to assess its efficacy and impact on AEs.METHODS We retrospectively analyzed data from 35 patients who underwent EGBS after PTGBD at a single center between January 2016 and December 2023.The primary outcomes were technical success and AEs,and the rate of recurrent cholecystitis was evaluated.In addition,the reasons for the failure of the procedure were identified.RESULTS Among the 35 patients,the technical success rate was 77.1%and the final contrast of the cystic duct was successful in 97.1%of patients.The incidence of early AEs was relatively low(11.4%),with no instances of cystic duct perforation.The rate of recurrent cholecystitis was 3.7%,and no other biliary events were observed.CONCLUSION EGBS after PTGBD may be significantly beneficial,with a substantial success rate and minimal AEs in both short-and long-term follow-ups.

关 键 词：ENDOSCOPY GALLBLADDER STENTS Drainage Adverse events CHOLECYSTITIS FOLLOW-UP Cystic duct 

分 类 号：R657.4[医药卫生—外科学]